Please login to the form below

Not currently logged in
Email:
Password:

EASD 2013

This page shows the latest EASD 2013 news and features for those working in and with pharma, biotech and healthcare.

Novo backs Victoza's prospects in Alzheimer's

Novo backs Victoza's prospects in Alzheimer's

Speaking to PMLiVE at the European Association for the Study of Diabetes' (EASD) 2013 meeting in Barcelona last week, Novo's chief science officer Mads Krogsgaard Thomsen confirmed the drug, approved ... the end of 2013.

Latest news

More from news
Approximately 4 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
OUTiCO

Providing an exceptional outsourcing service to the Pharma & Healthcare industries. We offer a sustainable approach and drive sales outcomes...

Latest intelligence

The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
Escaping the spin cycle of sub-optimal launch
...

Infographics